Home/Filings/4/0001142576-11-000036
4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-11-000036

CIK 0001142576other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 3:09 PM ET

Size

4.6 KB

Accession

0001142576-11-000036

Insider Transaction Report

Form 4
Period: 2011-11-15
Shue Youe Kong
VP, clinical Development
Transactions
  • Other

    Common stock

    2011-11-15$9.72/sh+1,186$11,53394,230 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on November 15, 2011.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380841

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 3:09 PM ET
Size
4.6 KB